• Increase
  • Decrease
  • Normal

Current Size: 100%

  • International Affiliate Members at Ed Forum 2019
    IWMF International Affiliates

    IWMF President, Carl Harrington, and Elena Malunis, IWMF Vice President of Member Services, at the 2019 Ed Forum with International Affiliate members.

  • Peter DeNardis
    The IWMF Is Here to Help You!

    Click on the image to view a video of Peter DeNardis, IWMF Board Member, as he explains how the Foundation helps everyone affected by WM.

  • Ed Forum 2019
    Imagine a Cure

    We have a goal of raising $25,000,000 to support WM research and vital member services through both current gifts and legacy gifts.

  • Ed Forum 2019 in front of Philadelphia Art Museum
    Living with WM

    There are many patients with Waldenstrom’s macroglobulinemia (WM) who are living well and enjoying life with a degree of contentment that may seem surprising to others.

  • Ed Forum walk June 2019 in Philadelphia
    IWMF Members

    All photos on our site are of IWMF members. 

We support everyone affected by Waldenstrom's macroglobulinemia
while advancing the search for a cure.


October 3, 2019

Michael was the first Australian to have ibrutinib treatment and it’s been lifesaving. “My life is normal now,” said Michael, 69, of Milton in regional New South Wales. 
View Michael's Story of Hope ...

September 30, 2019

IVIG Fact Sheet and WhiMSICAL Patient Registry are proving to be valuable sources of IVIG information to the WM patient/caregiver community and to the healthcare community.


September 12, 2019

With an emphasis on WM, the IWMF 2019 Human Intravenous Immunoglobulin Therapy (IVIG) Fact Sheet explains how the therapy is given, side effects, and self-care tips.


October 18, 2019
No. 160 Pujian Road
Pudong , 31
October 19, 2019
320 North Dearborn Street
Chicago , IL
United States
October 19, 2019
3410 Worth Street
Dallas , TX
United States
October 19, 2019
530 Starboard Drive
Halifax , NS
October 19, 2019
320 North Dearborn Street
Chicago , IL
United States

This website is supported in part by unrestricted educational grants from Pharmacyclics LLC  and Janssen Biotech, Inc.